Helge G. Bischoff
Universidad de Las Palmas de Gran Canaria
1 paper in the Anchorcite directory, published in 2018, cited 6,754 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Lung Cancer Diagnosis and Treatment · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
Frequent co-authors
- Leena Gandhi · 1 paper
- Delvys Rodríguez‐Abreu · 1 paper
- Shirish M. Gadgeel · 1 paper
- Emilio Esteban · 1 paper
- Enriqueta Felip · 1 paper
- Flávia De Angelis · 1 paper
- Manuel Dómine · 1 paper
- Philip R. Clingan · 1 paper
Papers
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine · 2018 · 6,754 citations
BACKGROUND: First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ligand 1 (PD-L1) of 50% or greater, pembrolizumab has replaced cytotoxic chemotherapy as the…
Metadata from OpenAlex (CC0).